Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

The association between immune-related AEs (irAE) and outcome in patients with sarcoma is not known. We retrospectively reviewed a cohort of patients with advanced sarcoma treated with immune checkpoint blockade (ICB)-based therapy. Association of irAEs with survival was assessed using a Cox regress...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenbaum, Evan, Seier, Kenneth, Bradic, Martina, Kelly, Ciara, Movva, Sujana, Nacev, Benjamin A., Gounder, Mrinal M., Keohan, Mary L., Avutu, Viswatej, Chi, Ping, Thornton, Katherine A., Chan, Jason E., Dickson, Mark A., Donoghue, Mark T.A., Tap, William D., Qin, Li-Xuan, D'Angelo, Sandra P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583739/
https://www.ncbi.nlm.nih.gov/pubmed/37787759
http://dx.doi.org/10.1158/2767-9764.CRC-22-0140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583739/
https://www.ncbi.nlm.nih.gov/pubmed/37787759
http://dx.doi.org/10.1158/2767-9764.CRC-22-0140

Ejemplares similares